Advertisement
Cardon Children's Medical Center

Roche's lung cancer combo treatment wins FDA approval

Dec 07, 2018 , Reuters
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.


Read the full story...


Trending healthcare news keywords at this moment

healthcare digital patients study finds data cancer disease kids mental heart medical drug fda research flu measles higher care teen risk big launches shows tech food depression tied surgery tip state products